Andreas Müller

Trials

Studies that name Andreas Müller as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:04 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT06750536 · Evaluating the Safety and Performance of the MiniLung Petite Kit in Neonatal and Pediatric Patients With Acute Respiratory and Cardiac Failure

  Xenios AG · recruiting · Extracorporeal Membrane Oxygenation Complication, Neonatal Aspiration Pneumonia, Acute Respiratory Failure · principal investigator
• N/A
  NCT06007170 · Performance of the SPIRION Laryngeal Pacemaker in BVFP Patients Without Glottal Enlargement

  MED-EL Elektromedizinische Geräte GmbH · active not recruiting · Bilateral Vocal Cord Paralysis · principal investigator
• N/A
  NCT06007144 · Performance of the SPIRION Laryngeal Pacemaker in BVFP Patients With Single-sided Glottal Enlargement

  MED-EL Elektromedizinische Geräte GmbH · terminated · Bilateral Vocal Cord Paralysis · principal investigator
• N/A
  NCT05691374 · Evaluation of Functional and Biomechanical Outcome by Shear-wave Elastography in the Short to Intermediate Follow-up After Arthroscopic Rotator Cuff Repair

  University Hospital, Basel, Switzerland · completed · Arthroscopic Rotator Cuff Repair (ARCR) · study director
• N/A
  NCT04342234 · Neural Network to Calculate Morphology of the Cleft Palate to Reduce Cleft Lip and Palate Treatment Burden.

  University Hospital, Basel, Switzerland · recruiting · Cleft Palate, Orofacial Cleft · principal investigator
• N/A
  NCT04321005 · Surgical Safety and Effectiveness in Orthopedics: Swiss-wide Multicenter Evaluation and Prediction of Core Outcomes in Arthroscopic Rotator Cuff Reconstruction

  University Hospital, Basel, Switzerland · completed · Rotator Cuff Tear · principal investigator
• N/A
  NCT03901209 · First-In-Man Performance and Safety Evaluation of the CARLO® Device in Midface Osteotomies

  Advanced Osteotomy Tools (AOT) AG · completed · Abnormalities, Jaw, Malocclusion, Angle Class III · principal investigator
• Ph3
  NCT02051218 · Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks

  Swiss Cancer Institute · terminated · Metastatic Breast Cancer, Metastatic Prostate Cancer, Bone Metastases · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-12 07:04 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.